Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Avadel Pharmaceuticals Total Assets 2011-2025 | AVDL

Avadel Pharmaceuticals total assets from 2011 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Avadel Pharmaceuticals Annual Total Assets
(Millions of US $)
2024 $164
2023 $165
2022 $133
2021 $247
2020 $312
2019 $151
2018 $190
2017 $253
2016 $245
2015 $215
2014 $174
2013 $116
2012 $117
2011 $69
2010 $75
Avadel Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2025-09-30 $199
2025-06-30 $187
2025-03-31 $168
2024-12-31 $164
2024-09-30 $158
2024-06-30 $158
2024-03-31 $168
2023-12-31 $165
2023-09-30 $203
2023-06-30 $201
2023-03-31 $141
2022-12-31 $133
2022-09-30 $146
2022-06-30 $158
2022-03-31 $221
2021-12-31 $247
2021-09-30 $264
2021-06-30 $283
2021-03-31 $293
2020-12-31 $312
2020-09-30 $328
2020-06-30 $341
2020-03-31 $208
2019-12-31 $151
2019-09-30 $156
2019-06-30 $166
2019-03-31 $174
2018-12-31 $190
2018-09-30 $269
2018-06-30 $295
2018-03-31 $352
2017-12-31 $253
2017-09-30 $277
2017-06-30 $259
2017-03-31 $259
2016-12-31 $245
2016-09-30 $248
2016-06-30 $250
2016-03-31 $255
2015-12-31 $215
2015-09-30 $0
2015-06-30 $187
2015-03-31 $186
2014-12-31 $174
2014-09-30 $164
2014-06-30 $175
2014-03-31 $182
2013-12-31 $116
2013-09-30 $117
2013-06-30 $118
2013-03-31 $123
2012-12-31 $117
2012-09-30 $0
2012-06-30 $134
2012-03-31 $137
2011-12-31 $69
2011-09-30 $73
2011-06-30 $76
2011-03-31 $70
2010-12-31 $75
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.248B $0.169B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $89.154B 33.86
Zoetis (ZTS) United States $52.354B 18.74
Takeda Pharmaceutical (TAK) Japan $44.993B 9.18
BeOne Medicines - (ONC) Switzerland $44.644B 218.97
Daiichi Sankyo, - (DSNKY) Japan $41.960B 20.90
Sandoz Group AG (SDZNY) Switzerland $30.210B 0.00
United Therapeutics (UTHR) United States $20.319B 17.88
Merck (MKKGY) Germany $17.344B 10.69
Shionogi (SGIOY) Japan $14.581B 13.39
Neurocrine Biosciences (NBIX) United States $14.314B 34.34
Summit Therapeutics (SMMT) United States $13.071B 0.00
IPSEN (IPSEY) France $12.602B 0.00
Madrigal Pharmaceuticals (MDGL) United States $12.569B 0.00
Ionis Pharmaceuticals (IONS) United States $11.866B 0.00
Orion OYJ (ORINY) Finland $9.803B 28.01
Eisai (ESAIY) $8.668B 0.00
Corcept Therapeutics (CORT) United States $7.902B 85.36
Stevanato Group S.p.A (STVN) Italy $6.514B 36.46
Grifols, S.A (GRFS) Spain $5.844B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.204B 15.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.586B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $4.372B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.130B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $3.672B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.640B 17.28
Hypermarcas (HYPMY) Brazil $3.072B 21.09
Procaps Group, S.A (PROCF) Luxembourg $2.926B 0.00
Dyne Therapeutics (DYN) United States $2.891B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.773B 8.85
Soleno Therapeutics (SLNO) United States $2.538B 0.00
Ocular Therapeutix (OCUL) United States $2.533B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.042B 24.20
Guardian Pharmacy Services (GRDN) United States $1.794B 34.55
Amylyx Pharmaceuticals (AMLX) United States $1.535B 0.00
Harrow (HROW) United States $1.492B 91.57
BioCryst Pharmaceuticals (BCRX) United States $1.480B 87.88
Ardelyx (ARDX) United States $1.436B 0.00
Collegium Pharmaceutical (COLL) United States $1.433B 7.10
Oruka Therapeutics (ORKA) United States $1.367B 0.00
Enliven Therapeutics (ELVN) United States $1.291B 0.00
Nektar Therapeutics (NKTR) United States $1.212B 0.00
Xeris Biopharma Holdings (XERS) United States $1.205B 0.00
Relay Therapeutics (RLAY) United States $1.147B 0.00
Xencor (XNCR) United States $1.115B 0.00
Evotec AG (EVO) Germany $1.052B 0.00
Cronos Group (CRON) Canada $0.927B 0.00
Theravance Biopharma (TBPH) United States $0.914B 38.38
Savara (SVRA) United States $0.855B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.772B 6.89
Organogenesis (ORGO) United States $0.760B 0.00
KalVista Pharmaceuticals (KALV) United States $0.751B 0.00
ARS Pharmaceuticals (SPRY) United States $0.724B 0.00
Aquestive Therapeutics (AQST) United States $0.710B 0.00
Lexeo Therapeutics (LXEO) United States $0.692B 0.00
Esperion Therapeutics (ESPR) United States $0.674B 0.00
ProKidney (PROK) United States $0.662B 0.00
4D Molecular Therapeutics (FDMT) United States $0.626B 0.00
Elite Pharmaceuticals (ELTP) United States $0.624B 0.00
Bioventus (BVS) United States $0.584B 11.97
Zevra Therapeutics (ZVRA) United States $0.517B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.508B 12.04
Akebia Therapeutics (AKBA) United States $0.467B 0.00
Altimmune (ALT) United States $0.437B 0.00
Siga Technologies (SIGA) United States $0.423B 5.78
Galectin Therapeutics (GALT) United States $0.387B 0.00
Lyell Immunopharma (LYEL) United States $0.370B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 21.39
USANA Health Sciences (USNA) United States $0.346B 9.65
Silence Therapeutics (SLN) United Kingdom $0.316B 0.00
Avalo Therapeutics (AVTX) United States $0.306B 0.00
Aldeyra Therapeutics (ALDX) United States $0.298B 0.00
Larimar Therapeutics (LRMR) United States $0.292B 0.00
Pyxis Oncology (PYXS) United States $0.290B 0.00
Aclaris Therapeutics (ACRS) United States $0.265B 0.00
Achieve Life Sciences (ACHV) Canada $0.234B 0.00
OmniAb (OABI) United States $0.219B 0.00
Protara Therapeutics (TARA) United States $0.215B 0.00
AleAnna (ANNA) United States $0.211B 0.00
MediWound (MDWD) Israel $0.204B 0.00
Journey Medical (DERM) United States $0.202B 0.00
Heron Therapeutics (HRTX) United States $0.200B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Innate Pharma SA (IPHYF) France $0.168B 0.00
China SXT Pharmaceuticals (SXTC) China $0.157B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.138B 0.00
Cassava Sciences (SAVA) United States $0.134B 0.00
Relmada Therapeutics (RLMD) United States $0.132B 0.00
Unicycive Therapeutics (UNCY) United States $0.124B 0.00
Avita Medical (RCEL) United States $0.118B 0.00
Incannex Healthcare (IXHL) Australia $0.117B 0.00
Inhibikase Therapeutics (IKT) United States $0.114B 0.00
Surrozen (SRZN) United States $0.110B 0.00
Vivani Medical (VANI) United States $0.107B 0.00
Context Therapeutics (CNTX) United States $0.106B 0.00
Prelude Therapeutics (PRLD) United States $0.104B 0.00
Gain Therapeutics (GANX) United States $0.102B 0.00
Karyopharm Therapeutics (KPTI) United States $0.099B 0.00
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
VAXART, INC (VXRT) United States $0.094B 0.00
Champions Oncology (CSBR) United States $0.093B 33.75
PMV Pharmaceuticals (PMVP) United States $0.076B 0.00
Acrivon Therapeutics (ACRV) United States $0.075B 0.00
Dominari Holdings (DOMH) United States $0.074B 0.00
Assertio Holdings (ASRT) United States $0.072B 0.00
Fractyl Health (GUTS) United States $0.072B 0.00
Lite Strategy (LITS) United States $0.070B 0.00
Plus Therapeutics (PSTV) United States $0.065B 0.00
Nutriband (NTRB) United States $0.065B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Rafael Holdings (RFL) United States $0.063B 0.00
Talphera (TLPH) United States $0.062B 0.00
BioNxt Solutions (BNXTF) Canada $0.061B 0.00
Korro Bio (KRRO) United States $0.058B 0.00
PolyPid (PYPD) Israel $0.058B 0.00
Wellgistics Health (WGRX) United States $0.052B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Jupiter Neurosciences (JUNS) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Century Therapeutics (IPSC) United States $0.042B 0.00
NRx Pharmaceuticals (NRXP) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.035B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Klotho Neurosciences (KLTO) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
Liminatus Pharma (LIMN) United States $0.029B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.028B 23.75
Vyome Holdings (HIND) United States $0.028B 0.00
Cosmos Health (COSM) United States $0.024B 0.00
SCYNEXIS (SCYX) United States $0.024B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Inotiv (NOTV) United States $0.024B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Natural Alternatives (NAII) United States $0.018B 0.00
Mannatech (MTEX) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.02
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Heatwurx (PCSA) United States $0.015B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
CASI Pharmaceuticals (CASI) China $0.015B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Mangoceuticals (MGRX) United States $0.013B 0.00
VYNE Therapeutics (VYNE) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
ProPhase Labs (PRPH) United States $0.011B 0.00
BioVie (BIVI) United States $0.011B 0.00
Ainos (AIMD) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.008B 0.00
Phio Pharmaceuticals (PHIO) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
Qualigen Therapeutics (QLGN) United States $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Nuvilex (PMCB) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CDT Equity (CDT) United States $0.003B 0.00
Indaptus Therapeutics (INDP) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
Indivior (INDV) United States $0.000B 16.01
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00